Freezing lung nodules: a new hope for inoperable patients?
NCT ID NCT07232433
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a procedure called cryoablation, which uses extreme cold to freeze and destroy lung nodules that are early-stage cancer. It is for people who cannot have surgery due to age or health issues. The trial will enroll 90 participants and follow them for up to 5 years to see if the cancer comes back and how safe the procedure is.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cryoablation (a procedure that freezes and destroys cancer cells)
What this could lead to
If successful, this could provide a safe and effective treatment option for people with early-stage lung cancer who are not candidates for surgery.
What could go wrong
This is a small, early-phase study with no control group, so results may not be definitive. Risks include pneumothorax, bleeding, or infection from the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
NOT_YET_RECRUITINGShanghai, Shanghai Municipality, 200025, China
-
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, 200025, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••